Stocks
IGM Biosciences (IGMS) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 4.55 | 1.28 | 1.74 | 1.16 | 0.69 | 3.33 | |||
| Changes by years, y/y, % | -16% | -72% | +36% | -33% | -40% | -33.7% | |||
IGM Biosciences. Debt/EBITDA
IGM Biosciences. Debt/EBITDA, changes, %
IGM Biosciences (IGMS) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | LTM ? | |||
| Debt/EBITDA | 0.95 | 0.77 | 0.69 | 0.61 | 3.33 | 3.33 | ||
| Changes by years, y/y, % | -34% | -45% | -40% | -41% | +250% | |||
| Changes by quarters, q/q, % | -8% | -20% | -9% | -13% | +450% | |||
